PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...

A new treatment combines standard hematoma surgery with an embolization (blocking) of the brain's middle meningeal artery, with the goal of avoiding repeat surgeries. Photo by Adobe Stock/HealthDay ...

The Onyx Liquid Embolic System (Medtronic) effectively occludes cerebral arteriovenous malformations (cAVMs), new observational data suggest. In a prospective, real-world study of more than 100 ...

The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...

(RTTNews) - Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy of the Onyx™ ...

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.

Assistant Professor Jesse Jones, M.D., has been tapped by Medtronic to lead UAB in a clinical trial aimed at treating subdural hematomas. The study is titled “ Embolization of the Middle Meningeal ...

Chronic subdural hematoma (cSDH) is frequently encountered in neurosurgical practice. Apart from traditional treatment approaches, such as surgical intervention or medical management, middle meningeal ...

TAMPA, Fla., March 23, 2021 /PRNewswire/ -- Tampa General Hospital, working with USF Health, is one of the first sites in the country – and the first in Florida – to enroll patients in a new national ...

A new LOCAL online community built for you. Click now to see all the available groups. New research finds that combining traditional surgery to drain the bleed and an embolization of a nearby artery ...